Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 8/20 | 1.00 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.64 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.61 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8732535 | 0.92 | CYSLTR1 (1.00) | CYSLTR1GPBAR1 | |
| SCHEMBL8732710 | 0.87 | CYSLTR1 (0.77) | CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL8733684 | 0.86 | CYSLTR1 (0.81) | CYSLTR1GPBAR1 | |
| SCHEMBL8734219 | 0.86 | CYSLTR1 (1.00) | CYSLTR1GPBAR1 | |
| SCHEMBL7452285 | 0.84 | CYSLTR1 (0.77) | CYSLTR1GPBAR1MRGPRX4CYSLTR2 | |
| SCHEMBL8733767 | 0.83 | CYSLTR1 (0.71) | CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL7010090 | 0.83 | CYSLTR1 (0.84) | CYSLTR1GPBAR1MRGPRX4CYSLTR2 | |
| SCHEMBL7801642 | 0.81 | GPBAR1 (0.81) | CYSLTR1GPBAR1 | |
| SCHEMBL8736480 | 0.81 | CYSLTR1 (0.96) | CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL9023239 | 0.81 | CYSLTR1 (0.82) | CYSLTR1GPBAR1CYSLTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0874826-A1 | NAPHTHALENE QUINOLINES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION | LABORATORIOS MENARINI S.A. (ES) | 1998-11-04 | — | — | EP | disclosed |
| WO-1997024331-A1 | NAPHTHALENE QUINOLINES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION | LABORATORIOS MENARINI S.A. (ES) | 1997-07-10 | — | — | WO | disclosed |